Search / 345 results found

from
to
  • Updated

Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Oct. 22 as the U.S. considers opening vaccinations to that age group.